# Filana Therapeutics, Inc.: Form 8-K, filed Sep 18, 2026

- Company: [Filana Therapeutics, Inc.](/companies/flna.md) (CIK 1069530)
- Form: 8-K
- Filed: 2026-09-18
- Accepted by EDGAR: Sep 18, 2026, 20:16 ET
- Period: 2026-09-17
- Accession: 0001437749-26-030751
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1069530/000143774926030751/sava20260918_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1069530/000143774926030751/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1069530/000143774926030751/sava20260918_8k.htm

Filed Sep 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-030751. Last ingested by Listed: Oct 24, 2026, 15:03 ET. No prices; not investment advice.